US Broker Ratings

Glaukos Corporation (GKOS) Stock Analysis: Eyeing a 20.52% Upside with Innovative Medical Solutions

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its promising growth potential. With a market capitalization..

GSK plc (GSK) Stock Analysis: Unveiling a Promising 11.77% Potential Upside

With a commanding presence in the healthcare sector, GSK plc (GSK) stands as a formidable player in the Drug Manufacturers – General industry. Headquartered in London, United Kingdom, this pharmaceutical..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings and Innovative Healthcare Solutions Drive Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, has garnered significant investor interest due to its robust pipeline of diagnostic and therapeutic products. With a market..

DaVita Inc. (DVA) Stock Analysis: Navigating Growth Amidst a Dynamic Healthcare Landscape

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within medical care facilities, offers kidney dialysis services to individuals with chronic kidney failure in the United States...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Potential Upside of Over 22% Amidst Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable name in the healthcare sector, is capturing investor attention with its innovative approach to tackling obstructive sleep apnea (OSA) through minimally invasive..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Points to Over 100% Upside for This Innovative Biotech Stock

Telix Pharmaceuticals Limited (ASX: TLX), a key player in the biotechnology sector focusing on radiopharmaceuticals, stands out with a compelling growth narrative and robust analyst support. Headquartered in North Melbourne,..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring the 10.19% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, specifically in medical distribution, is attracting investor attention with its solid market presence and potential upside of 10.19%...

Bio-Techne Corp (TECH) Stock Analysis: Evaluating Its 5.81% Potential Upside with Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, operates within the dynamic biotechnology industry. With a market capitalization of $9.07 billion, Bio-Techne has been a beacon of..

Incyte Corporation (INCY) Stock Analysis: Exploring Growth, Analyst Consensus, and Potential Upside

Incyte Corporation (INCY), a leading player in the biotechnology sector, is attracting investor attention with its promising pipeline and robust financial metrics. Headquartered in Wilmington, Delaware, this biopharmaceutical company is..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Leader with 57.4% Revenue Growth and Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector, with its focus on developing innovative therapies for central nervous system (CNS) disorders. Headquartered in New York and..

Guardant Health, Inc. (GH) Stock Analysis: Why Investors Should Look Beyond the Numbers

Guardant Health, Inc. (NASDAQ: GH) is carving a niche in the precision oncology sector, offering investors a compelling narrative that extends beyond traditional financial metrics. With a market capitalization of..

DexCom, Inc. (DXCM) Stock Analysis: Navigating a 17.58% Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM) stands out as a significant player in the healthcare sector, particularly within the medical devices industry. The company, headquartered in San Diego, California, has carved a..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Look at the 34.22% Upside Potential

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable force in the healthcare sector, commanding a market capitalization of $83.23 billion. With its operations rooted in the United States, HCA..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 54% Potential Upside in Biotechnology

In a landscape where biopharmaceutical innovation is as competitive as it is promising, BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out with a market capitalization of $12.98 billion. This Palo Alto-based..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Growth with a 14.87% Potential Upside

For investors eyeing opportunities in the healthcare sector, Teleflex Incorporated (NYSE: TFX) presents an intriguing proposition. With a market capitalization of $5.62 billion, this U.S.-based company is a significant player..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Through the Biotech Maze with a $5.94 Billion Valuation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based biotech firm specializing in Traditional Chinese Medicine (TCM), finds itself at a crucial juncture. With a market capitalization of $5.94 billion,..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 43% Potential Upside

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Birmingham, Alabama, the company has established a robust..

Nuvalent, Inc. (NUVL) Stock Analysis: Investor Outlook and Growth Potential in Biotech

Nuvalent, Inc. (NASDAQ: NUVL), a promising player in the biotechnology sector, is catching the attention of investors, particularly with its potential upside of 3.80% as highlighted by analyst ratings. As..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 39% Potential Upside Amidst Solid Growth

ResMed Inc. (NYSE: RMD) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $27.36 billion, the company..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 35.93% Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, specializes in eye care solutions, offering a comprehensive range of products and services aimed at enhancing vision care worldwide...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds